China Universal Asset Management »

Protagonist Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $324k 11k 28.95
2023-12-31 $153k 6.7k 22.92
2023-09-30 $25k 1.5k 16.97
2023-06-30 $21k 750 28.00
2023-03-31 $15k 667 22.49
2022-12-31 $5.0k 500 10.00
2022-09-30 $4.0k 460 8.70

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Protagonist Therapeutics

BVF
Vanguard Group
Point72 Asset Management
Kynam Capital Management
Cowen And Company
Leucadia National Corporation
Deutsche Bank Aktiengesellschaft
T. Rowe Price Associates
Dimensional Fund Advisors
683 Capital Management
Goldman Sachs Group
Charles Schwab Investment Management
Citadel Advisors
Jpmorgan Chase & Co
Gratus Capital

View all funds holding Protagonist Therapeutics